Correlation Between Hepatic Fibrosis and Cardiovascular Risk Evaluated by Non-invasive Tests in Patients With NAFLD (Cardio-NASH)

Clinique Pasteur

Status: Completed

Conditions: NAFLD

Study type: Observational

Funder types: Other

Identifiers

NCT04774302

2020-A03423-36

Details and patient eligibility

About

This study aims to examine the link between Non-Alcoholic Fatty Liver Disease (NAFLD) and cardiovascular diseases by studying the association between liver fibrosis degree and cardiovascular risk factors. The study would clarify the value and the role of the Coronary calcium score (CAC score) in the screening for coronary disease in this population at high cardiovascular risk.

Full description

Hepatic Fibrosis and Cardiovascular Risk are evaluated by non invasive tests

Enrollment: 292 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• NAFLD patients regardless of disease stage of severity (from simple steatosis to cirrhosis)
• Patient without known heart disease
• Patient agreeing to participate and who has given his non opposition

Exclusion criteria

• Association with another cause of liver disease
• Already known coronary artery disease
• Pregnancy or breastfeeding in progress